课题基金 / 基金详情

Cancer diagnosis with Positron Emission Tomography ; Development of a new tyrosine analogue

Cancer diagnosis with Positron Emission Tomography ; Development of a new tyrosine analogue
正电子发射断层扫描癌症诊断;
批准号:
16390349
负责人:
KUBOTA Kazuo
金额:
$7.44万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2007

项目摘要

项目成果

KUBOTA Kazuo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aim of study is the development of a new amino acid analogue O-[11C]methyl-L-tyrosine (OMT) and its first clinical application to whole-body imaging as well as brain tumor imaging. OMT was firstly prepared with a high radiochemical yield by the methylation of L-tyrosine with [^<11>C]methyl triflate followed by HPLC purification (Iwata et al., 2002). Later, the simple automated method using the solid phase extraction without HPLC purification was developed for routine clinical use (Ishikawa et al., 2005).Seventeen patients (13 male, 4 female, mean age 69, range 46-89) of various types of cancer or suspected of cancer with 24 lesions were studied with OMT-PET. Sixteen patients have been studied with FDG-PET also within a week.Diagnostic accuracy for all lesions were calculated as follows : sensitivity of OMT 75% (12/16) and FDG 94% (15/16) ; specificity of OMT 75% (6/8) and FDG 43% (3/7) ; and accuracy of OMT 75% (18/24) and FDG 78% (18/23). Chronic xantomatous cholecystitis showed r … More ing like uptake with FDG, but no significant uptake with OMT. Tumor to background ratios (T/B ratios) of lung cancer and brain tumor were around 2.0. Mean SUV values of malignant and benign lesions with OMT-PET and FDG-PET were as follows : OMT malignant 2.26±1.44 (n=16), OMT benign 2.25±1.33 (n=8), FDG malignant 5.98±3.38 (n=16), FDG benign 4.79±2.64 (n=7). There were no significant differences between malignant and benign neither with FDG nor OMT.As the normal distribution, liver and pancreas uptake of OMT was mild, but urinary excretion was observed from early after injection. Normal brain uptake was lower than the liver, and slightly higher than the muscle. Kidney and urine in the bladder showed the highest activity. Results were summarized as follows;1. OMT uptake by tumor was tended lower than the FDG.2. OMT uptake by inflammation was tended lower than the FDG.3. In some tumors, such as esophageal cancer, gall bladder cancer, OMT-PET may be helpful to avoid false positive results that was derived by FDG uptake of active inflammation. Less
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2004
期刊: European Journal of Nuclear Medicine 31
影响因子: --
作者: [Kubota K, Yokoyama J, Yamaguchi K, et al.]
通讯作者: et al.
DOI: 10.1007/s12149-007-0039-6
发表时间: 2007-09-01
期刊: ANNALS OF NUCLEAR MEDICINE
影响因子: 2.6
作者: [Ito, Kimiteru, Kubota, Kazuo, Sasao, Yuki]
通讯作者: Sasao, Yuki
DOI: 10.1111/j.1349-7006.2008.00834.x
发表时间: 2008-07-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者: [Hori, Katsuyoshi, Furumoto, Shozo, Kubota, Kazuo]
通讯作者: Kubota, Kazuo
Cold tuberculous abscess identified by FDG-PET.
FDG-PET 鉴别冷结核性脓肿。
DOI: --
发表时间: 2005
期刊: Annals of Nuclear Medicine Vol 19
影响因子: --
作者: [Yago Y, Yukihiro M, Kuroki H, Katsuragawa Y, Kubota K.]
通讯作者: Kubota K.
26
    A study for the diagnosis of inflammatory diseases of joint and spine using FDG-PET; prospective and retrospective studies
    In TOW SONG ERA the FUNDAMENTAL PROBLEM on THE CAPITALS
    • 批准号:
      15520442
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      2003
    • 负责人:
      KUBOTA Kazuo
    • 依托单位:
    A new progress of physical therapy for the purpose of prevention of cerebrovascular and infeetious diseases
    • 批准号:
      12832011
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2000
    • 负责人:
      KUBOTA Kazuo
    • 依托单位:
    PREDICTION OF RADIOTHERAPEUTIC EFFECTS ON TUMOR USING POSITRON EMISSION TOMOGRAPHY
    • 批准号:
      09470195
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.74万
    • 财政年份:
      1997
    • 负责人:
      KUBOTA Kazuo
    • 依托单位:
    海外基金